| Typicality: | 0.303 |
| Saliency: | 0.328 |
| on drug interactions | 7 | other |
| on product benefits | 6 | other |
| about actual proof of its effectiveness | 6 | other |
| manufacturer → offer → little information | 14 |
| manufacturer → provide → little information | 5 |
| manufacturer → not provide → much information | 4 |
| negative | neutral | positive |
| 0.498 | 0.462 | 0.040 |
| Raw frequency | 23 |
| Normalized frequency | 0.328 |
| Modifier score | 0.500 |
| Perplexity | 248.228 |